Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 20 New Entrants companies in Hyperlipidemia
by Most Patent Filing In 5 Years in the United States in 2019

The Hyperlipidemia top 20 is Discovery PatSnap’ annual ranking of the top 20 Most Patent Filing In 5 Years Hyperlipidemia New Entrants in the United States. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2019, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
Hyperlipidemia is abnormally elevated levels of any or all lipids or lipoproteins in the blood. It is the most common form of dyslipidemia (which includes any abnormal lipid levels). Lipids (water-insoluble molecules) are transported in a protein capsule. The size of that capsule, or lipoprotein, determines its density. The lipoprotein density and type of apolipoproteins it contains determines the fate of the particle and its influence on metabolism.
#
Company Name
Region
Tech Topics
Total
1
Medicine,Health care,Pharmacy and Therapeutics,
...[+2]
Patent: 18
2
Arrowhead,Nanotechnology,Biotechnology,
...[+2]
Patent: 17
3
Patent: 11
4
Pharmacy and Therapeutics,Cardiovascular agent,Drug discovery,
...[+2]
Patent: 9
5
Vocational education,Business administration
Patent: 6
6
Patent: 5
7
Patent: 5
8
Arkay Therapeutics LLC
Diabetes Therapy,Health care
Patent: 4
9
Health care,Curcumin,Feed additive,
...[+2]
Patent: 4
10
Diabetes Therapy,Health care,Pharmacy and Therapeutics,
...[+2]
Patent: 4
11
Patent: 3
12
Patent: 3
13
Medical school,Health care,Diabetes Therapy,
...[+2]
Patent: 3
14
Patent: 2
15
Patent: 1
16
Patent: 1
17
Patent: 1
18
Patent: 1
19
Clinical trial,Medicine,Health care,
...[+2]
Patent: 1
20
Biosimilar,Pharmacy and Therapeutics,Medicine,
...[+2]
Patent: 1
Page generation time: May 23 2025